Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Screening Study to Characterize the Prevalence of the KIT D816V Mutation in Patients With Suspected Clonal Mast Cell Disease

NCT07143669 is registered in ClinicalTrials.gov with Blueprint Medicines Corporation as lead sponsor.

NCT NCT07143669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Screening Study to Characterize the Prevalence of the KIT D816V Mutation in Patients With Suspected Clonal Mast Cell Disease
Lead sponsor
Blueprint Medicines Corporation
Phase
Observational
Overall status
Recruiting
Start date
October 17, 2025
Completion date
October 31, 2028
Enrollment
750 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

clonal mast cell disease, kit d816v mutation, suspected kitd816v mutated clonal mast cell disease